The more you know can help reduce a patient’s risk of developing diabetes
Diabetes is a worldwide epidemic expected to grow to 522 Million cases by 2030.1
A key in fighting this epidemic is identifying a person’s increased risk for developing diabetes. Because early detection is key to preventing complications, we at Abbott are dedicated to helping individuals know the signs, symptoms and risk factors of this rapidly growing epidemic.
On World Diabetes Day — and every day — we help you provide highly accurate and immediate results during patient consultations that can lead to better care and outcomes for those in your care/for your patients.
Diagnosing Patients with Diabetes Just Got Easier
There’s a reason why the HbA1c test is considered a powerhouse by leading diabetes experts.2 An HbA1c test can not only identify pre-diabetes which raises a patient’s risk for diabetes, it can diagnose diabetes and help monitor a patient’s treatment progress over time.2
For healthcare providers, it is now easier to diagnose a patient at the point of care.
The highly accurate, three minute Afinion™ HbA1c Dx developed by Abbott is the first-ever point-of-care HbA1c test cleared in the United States as an aid in diagnosing diabetes.3
Being able to test, diagnose and treat in the moment has been proven to improve the patient’s motivation, attitude, and even their relationship with their clinician.4
Rapid diagnostic solutions to help you fight diabetes
Consultations with patients who do not have their lab results are more challenging and inefficient. The good news is point of care testing is ADA compliant and proven to lower HbA1c levels.
Accurate, actionable results from the leader in point-of-care lipid testing.
The CLIA-waived Cholestech LDX™ System helps monitor your at-risk patients. Engineered for confidence, this analyzer provides accurate, actionable, and readily accessible results for point-of-care lipid profile, cholesterol, and glucose testing.
Your First Point-of-Care.
NycoCard™ READER II is a multi assay instrument for point-of-care testing. With NycoCard READER II, healthcare professionals in doctors’ offices, clinics and hospitals will obtain accurate, quantitative results within minutes. Available tests include NycoCard™ HbA1c and NycoCard™ U-Albumin.